Literature DB >> 23749177

The dark side of TRAIL signaling.

S Fulda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749177      PMCID: PMC3679462          DOI: 10.1038/cdd.2013.36

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  6 in total

Review 1.  New insights into apoptosis signaling by Apo2L/TRAIL.

Authors:  F Gonzalvez; A Ashkenazi
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Identification and characterization of a new member of the TNF family that induces apoptosis.

Authors:  S R Wiley; K Schooley; P J Smolak; W S Din; C P Huang; J K Nicholl; G R Sutherland; T D Smith; C Rauch; C A Smith
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

Review 3.  Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.

Authors:  Christian Röder; Anna Trauzold; Holger Kalthoff
Journal:  Eur J Cell Biol       Date:  2010-12-03       Impact factor: 4.492

Review 4.  Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation.

Authors:  Annie Yang; Nicholas S Wilson; Avi Ashkenazi
Journal:  Curr Opin Cell Biol       Date:  2010-08-31       Impact factor: 8.382

5.  Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.

Authors:  R M Pitti; S A Marsters; S Ruppert; C J Donahue; A Moore; A Ashkenazi
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

Review 6.  Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.

Authors:  K Azijli; B Weyhenmeyer; G J Peters; S de Jong; F A E Kruyt
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

  6 in total
  5 in total

Review 1.  Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells.

Authors:  Rachana Trivedi; Durga Prasad Mishra
Journal:  Front Oncol       Date:  2015-04-02       Impact factor: 6.244

2.  Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.

Authors:  Birgit C Weyhenmeyer; Janis Noonan; Maximilian L Würstle; Frank A Lincoln; Grainne Johnston; Markus Rehm; Brona M Murphy
Journal:  Oncotarget       Date:  2016-09-20

Review 3.  Insight into the divergent role of TRAIL in non-neoplastic neurological diseases.

Authors:  Shiqi Gao; Yuanjian Fang; Sheng Tu; Huaijun Chen; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-08-22       Impact factor: 5.310

4.  TRAIL signaling promotes entosis in colorectal cancer.

Authors:  Emir Bozkurt; Heiko Düssmann; Manuela Salvucci; Brenton L Cavanagh; Sandra Van Schaeybroeck; Daniel B Longley; Seamus J Martin; Jochen H M Prehn
Journal:  J Cell Biol       Date:  2021-09-21       Impact factor: 10.539

Review 5.  Promising Antineoplastic Actions of Melatonin.

Authors:  Gaia Favero; Enrico Moretti; Francesca Bonomini; Russel J Reiter; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Front Pharmacol       Date:  2018-10-16       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.